Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP). ADMET DMPK. 2016;4(4):302-313. doi:10.5599/admet.4.4.322